Ling Jong

1.6k total citations
22 papers, 1.2k citations indexed

About

Ling Jong is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ling Jong has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Genetics and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ling Jong's work include Estrogen and related hormone effects (12 papers), Retinoids in leukemia and cellular processes (12 papers) and Nuclear Receptors and Signaling (5 papers). Ling Jong is often cited by papers focused on Estrogen and related hormone effects (12 papers), Retinoids in leukemia and cellular processes (12 papers) and Nuclear Receptors and Signaling (5 papers). Ling Jong collaborates with scholars based in United States, France and United Kingdom. Ling Jong's co-authors include Marcia I. Dawson, Magnus Pfahl, James F. Cameron, Peter D. Hobbs, Andrea Fanjul, Jürgen M. Lehmann, Xian Lu, Eli Harlev, Gerhart Graupner and Wan-Ru Chao and has published in prestigious journals such as Nature, Science and Molecular and Cellular Biology.

In The Last Decade

Ling Jong

22 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Jong United States 14 971 512 244 177 165 22 1.2k
Wan‐Ru Chao Taiwan 18 582 0.6× 224 0.4× 114 0.5× 120 0.7× 64 0.4× 56 846
Rosemary E. Hall Australia 17 701 0.7× 843 1.6× 58 0.2× 56 0.3× 59 0.4× 18 1.5k
Xiaohua Leng China 13 1.2k 1.2× 552 1.1× 27 0.1× 25 0.1× 121 0.7× 15 1.5k
Surinder K. Chander United Kingdom 23 853 0.9× 933 1.8× 15 0.1× 325 1.8× 29 0.2× 38 1.7k
Anhco Nguyen United States 6 1.1k 1.1× 159 0.3× 26 0.1× 34 0.2× 33 0.2× 7 1.2k
Da-Sheng Wang United States 12 696 0.7× 39 0.1× 36 0.1× 68 0.4× 33 0.2× 13 1.1k
D End United States 16 744 0.8× 70 0.1× 14 0.1× 161 0.9× 164 1.0× 18 1.2k
Silvia Fernández de Mattos Spain 18 1.1k 1.2× 70 0.1× 20 0.1× 76 0.4× 27 0.2× 31 1.6k
Susan E. Kiefer United States 14 622 0.6× 226 0.4× 13 0.1× 237 1.3× 31 0.2× 21 1.4k
Jeffrey D. Bray United States 12 441 0.5× 224 0.4× 9 0.0× 47 0.3× 23 0.1× 20 885

Countries citing papers authored by Ling Jong

Since Specialization
Citations

This map shows the geographic impact of Ling Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Jong more than expected).

Fields of papers citing papers by Ling Jong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Jong. The network helps show where Ling Jong may publish in the future.

Co-authorship network of co-authors of Ling Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Jong. A scholar is included among the top collaborators of Ling Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Jong. Ling Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reid, Joel M., Chad A. Walden, Rui Qin, et al.. (2011). Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668. Cancer Prevention Research. 4(3). 347–353. 16 indexed citations
2.
Green, Carol E., Robert R. Swezey, James Bakke, et al.. (2010). Improved oral bioavailability in rats of SR13668, a novel anti-cancer agent. Cancer Chemotherapy and Pharmacology. 67(5). 995–1006. 8 indexed citations
3.
Chao, Wan-Ru, Khalid Amin, Yihui Shi, et al.. (2010). SR16388: a steroidal antiangiogenic agent with potent inhibitory effect on tumor growth in vivo. Angiogenesis. 14(1). 1–16. 8 indexed citations
4.
Kapetanović, Izet M., Miguel Muzzio, James A. Crowell, et al.. (2009). Pharmacokinetics and enhanced bioavailability of candidate cancer preventative agent, SR13668 in dogs and monkeys. Cancer Chemotherapy and Pharmacology. 65(6). 1109–1116. 14 indexed citations
5.
6.
Jong, Ling, et al.. (2007). Nonprofit model for drug discovery and development. Drug Development Research. 68(4). 186–196. 1 indexed citations
7.
He, Hua, et al.. (2005). Signaling-Transduction Pathways Required for Ex Vivo Expansion of Human Limbal Explants on Intact Amniotic Membrane. Investigative Ophthalmology & Visual Science. 47(1). 151–151. 16 indexed citations
8.
Dawson, Marcia I., Danni L. Harris, Gang Liu, et al.. (2004). Antagonist Analogue of 6-[3‘-(1-Adamantyl)-4‘-hydroxyphenyl]-2-naphthalenecarboxylic Acid (AHPN) Family of Apoptosis Inducers That Effectively Blocks AHPN-Induced Apoptosis but Not Cell-Cycle Arrest. Journal of Medicinal Chemistry. 47(14). 3518–3536. 36 indexed citations
9.
Jong, Ling, Nurulain T. Zaveri, & Lawrence Toll. (2003). The design and synthesis of a novel quinolizidine template for potent opioid and opioid receptor-like (ORL1, NOP) receptor ligands. Bioorganic & Medicinal Chemistry Letters. 14(1). 181–185. 8 indexed citations
10.
Dawson, Marcia I., Ling Jong, Peter D. Hobbs, et al.. (2000). 4-[3-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoic acid and heterocyclic-bridged analogues are novel retinoic acid receptor subtype and retinoid X receptor α agonists. Bioorganic & Medicinal Chemistry Letters. 10(12). 1311–1313. 12 indexed citations
11.
Dawson, Marcia I., Peter D. Hobbs, Ling Jong, et al.. (2000). sp2-bridged diaryl retinoids: Effects of bridge-region substitution on retinoid x receptor (RXR) selectivity. Bioorganic & Medicinal Chemistry Letters. 10(12). 1307–1310. 8 indexed citations
12.
13.
Fontana, Joseph A., Mark Leid, Arun K. Rishi, et al.. (2000). Identification of a unique binding protein specific for a novel retinoid inducing cellular apoptosis. International Journal of Cancer. 86(4). 474–479. 12 indexed citations
14.
Li, Yin, Marcia I. Dawson, Anissa Agadir, et al.. (1998). Regulation of RARβ expression by RAR- and RXR-selective retinoids in human lung cancer cell lines: Effect on growth inhibition and apoptosis induction. International Journal of Cancer. 75(1). 88–95. 66 indexed citations
15.
16.
Wu, Qiao, Marcia I. Dawson, Yun Zheng, et al.. (1997). Inhibition of trans-Retinoic Acid-Resistant Human Breast Cancer Cell Growth by Retinoid X Receptor-Selective Retinoids. Molecular and Cellular Biology. 17(11). 6598–6608. 80 indexed citations
17.
Dawson, Marcia I., Ling Jong, Peter D. Hobbs, et al.. (1995). Conformational Effects on Retinoid Receptor Selectivity. 2. Effects of Retinoid Bridging Group on Retinoid X Receptor Activity and Selectivity. Journal of Medicinal Chemistry. 38(17). 3368–3383. 67 indexed citations
18.
Fanjul, Andrea, Marcia I. Dawson, Peter D. Hobbs, et al.. (1994). A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature. 372(6501). 107–111. 268 indexed citations
19.
Jong, Ling, Jürgen M. Lehmann, Peter D. Hobbs, et al.. (1993). Conformational effects on retinoid receptor selectivity. 1. Effect of 9-double bond geometry on retinoid X receptor activity. Journal of Medicinal Chemistry. 36(18). 2605–2613. 30 indexed citations
20.
Lehmann, Jürgen M., Ling Jong, Andrea Fanjul, et al.. (1992). Retinoids Selective for Retinoid X Receptor Response Pathways. Science. 258(5090). 1944–1946. 293 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wan‐Ru Chao Breakdown of academic impact, for papers by Rosemary E. Hall Breakdown of academic impact, for papers by Xiaohua Leng Breakdown of academic impact, for papers by Surinder K. Chander Breakdown of academic impact, for papers by Anhco Nguyen Breakdown of academic impact, for papers by Da-Sheng Wang Breakdown of academic impact, for papers by D End Breakdown of academic impact, for papers by Silvia Fernández de Mattos Breakdown of academic impact, for papers by Susan E. Kiefer Breakdown of academic impact, for papers by Jeffrey D. Bray
Rankless by CCL
2026